Zongsheng Yin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zongsheng Yin has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Hao Tang
Department of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Hefei, China
3 shared publicationsLi Yin
Department of Orthopedics, the First Affiliated Hospital of AnHui Medical University, HeFei, China
3 shared publicationsWeilu Gao
Department of Orthopedics, the First Affiliated Hospital of AnHui Medical University, HeFei, China
3 shared publicationsGongwen Du
Department of Orthopedics, the First Affiliated Hospital of AnHui Medical University, HeFei, China
2 shared publicationsHui Zhang
Department of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
2 shared publicationsSheng-Quan Zhang
Department of Biochemistry and Molecular Biology, Anhui Medical University, Hefei 230032, China
2 shared publications
Latest Publications
- Open Access
- 6 March 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
DJ-1 promotes necroptosis of chondrocytes by the PTEN/PI3K-AKT signaling pathway
Osteoarthritis (OA) is a common degenerative joint disease characterized by progressive cartilage degradation. Necroptosis has been recognized as a process closely associated with OA progression; however, its precise underlying mechanisms remain elusive. In this study, we found that the expression levels of DJ-1 and p-MLKL were significantly elevated in human OA cartilage tissue. Transmission electron microscopy revealed typical necroptotic morphology in OA chondrocytes. In vitro experiments demonstrated that DJ-1 overexpression exacerbated TSZ + LPS-induced chondrocyte necroptosis and disrupted extracellular matrix (ECM) metabolism. The PI3K/AKT signaling pathway can be involved in TNF-mediated necroptosis, while PTEN, as a negative regulator, inhibits the activation of this pathway primarily by dephosphorylating phosphatidylinositol (3,4,5)-trisphosphate (PIP3). Co-immunoprecipitation (Co-IP) assays showed that DJ-1 directly binds to and inhibits PTEN, thereby relieving its suppression of the PI3K/AKT signaling pathway. Treatment with the PI3K inhibitor LY294002 significantly alleviated DJ-1-induced chondrocyte necroptosis and ECM dysregulation. Furthermore, in vivo studies confirmed that DJ-1 knockdown attenuated DMM-induced OA progression and improved cartilage and subchondral bone structure. Collectively, these findings indicate that DJ-1 promotes chondrocyte necroptosis and ECM degradation through regulation of the PTEN/PI3K/AKT signaling pathway, thereby accelerating the onset and progression of OA. This may provide a new therapeutic target for the treatment of OA.
- 6 March 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
Open AccessDJ-1 promotes necroptosis of chondrocytes by the PTEN/PI3K-AKT signaling pathway
Osteoarthritis (OA) is a common degenerative joint disease characterized by progressive cartilage degradation. Necroptosis has been recognized as a process closely associated with OA progression; however, its precise underlying mechanisms remain elusive. In this study, we found that the expression levels of DJ-1 and p-MLKL were significantly elevated in human OA cartilage tissue. Transmission electron microscopy revealed typical necroptotic morphology in OA chondrocytes. In vitro experiments demonstrated that DJ-1 overexpression exacerbated TSZ + LPS-induced chondrocyte necroptosis and disrupted extracellular matrix (ECM) metabolism. The PI3K/AKT signaling pathway can be involved in TNF-mediated necroptosis, while PTEN, as a negative regulator, inhibits the activation of this pathway primarily by dephosphorylating phosphatidylinositol (3,4,5)-trisphosphate (PIP3). Co-immunoprecipitation (Co-IP) assays showed that DJ-1 directly binds to and inhibits PTEN, thereby relieving its suppression of the PI3K/AKT signaling pathway. Treatment with the PI3K inhibitor LY294002 significantly alleviated DJ-1-induced chondrocyte necroptosis and ECM dysregulation. Furthermore, in vivo studies confirmed that DJ-1 knockdown attenuated DMM-induced OA progression and improved cartilage and subchondral bone structure. Collectively, these findings indicate that DJ-1 promotes chondrocyte necroptosis and ECM degradation through regulation of the PTEN/PI3K/AKT signaling pathway, thereby accelerating the onset and progression of OA. This may provide a new therapeutic target for the treatment of OA.
- Open Access
- 25 April 2024
- Published by Springer Nature in Molecular Medicine
- Vol. 30 (1) , 1-14
CHMP5 attenuates osteoarthritis via inhibiting chondrocyte apoptosis and extracellular matrix degradation: involvement of NF-κB pathway
Background: Osteoarthritis (OA), the most common joint disease, is linked with chondrocyte apoptosis and extracellular matrix (ECM) degradation. Charged multivesicular body protein 5 (CHMP5), a member of the multivesicular body, has been reported to serve as an anti-apoptotic protein to participate in leukemia development. However, the effects of CHMP5 on apoptosis and ECM degradation in OA remain unclear. Methods: In this study, quantitative proteomics was performed to analyze differential proteins between normal and OA patient articular cartilages. The OA mouse model was constructed by the destabilization of the medial meniscus (DMM). In vitro, interleukin-1 beta (IL-1β) was used to induce OA in human chondrocytes. CHMP5 overexpression and silencing vectors were created using an adenovirus system. The effects of CHMP5 on IL-1β-induced chondrocyte apoptosis were investigated by CCK-8, flow cytometry, and western blot. The effects on ECM degradation were examined by western blot and immunofluorescence. The potential mechanism was explored by western blot and Co-IP assays. Results: Downregulated CHMP5 was identified by proteomics in OA patient cartilages, which was verified in human and mouse articular cartilages. CHMP5 overexpression repressed cell apoptosis and ECM degradation in OA chondrocytes. However, silencing CHMP5 exacerbated OA chondrocyte apoptosis and ECM degradation. Furthermore, we found that the protective effect of CHMP5 against OA was involved in nuclear factor kappa B (NF-κB) signaling pathway. Conclusions: This study demonstrated that CHMP5 repressed IL-1β-induced chondrocyte apoptosis and ECM degradation and blocked NF-κB activation. It was shown that CHMP5 might be a novel potential therapeutic target for OA in the future.
- 25 April 2024
- Published by Springer Nature in Molecular Medicine
- Vol. 30 (1) , 1-14
Open AccessCHMP5 attenuates osteoarthritis via inhibiting chondrocyte apoptosis and extracellular matrix degradation: involvement of NF-κB pathway
Background: Osteoarthritis (OA), the most common joint disease, is linked with chondrocyte apoptosis and extracellular matrix (ECM) degradation. Charged multivesicular body protein 5 (CHMP5), a member of the multivesicular body, has been reported to serve as an anti-apoptotic protein to participate in leukemia development. However, the effects of CHMP5 on apoptosis and ECM degradation in OA remain unclear. Methods: In this study, quantitative proteomics was performed to analyze differential proteins between normal and OA patient articular cartilages. The OA mouse model was constructed by the destabilization of the medial meniscus (DMM). In vitro, interleukin-1 beta (IL-1β) was used to induce OA in human chondrocytes. CHMP5 overexpression and silencing vectors were created using an adenovirus system. The effects of CHMP5 on IL-1β-induced chondrocyte apoptosis were investigated by CCK-8, flow cytometry, and western blot. The effects on ECM degradation were examined by western blot and immunofluorescence. The potential mechanism was explored by western blot and Co-IP assays. Results: Downregulated CHMP5 was identified by proteomics in OA patient cartilages, which was verified in human and mouse articular cartilages. CHMP5 overexpression repressed cell apoptosis and ECM degradation in OA chondrocytes. However, silencing CHMP5 exacerbated OA chondrocyte apoptosis and ECM degradation. Furthermore, we found that the protective effect of CHMP5 against OA was involved in nuclear factor kappa B (NF-κB) signaling pathway. Conclusions: This study demonstrated that CHMP5 repressed IL-1β-induced chondrocyte apoptosis and ECM degradation and blocked NF-κB activation. It was shown that CHMP5 might be a novel potential therapeutic target for OA in the future.
- Open Access
- 22 March 2024
- Published by Wiley in Journal of Cell Communication and Signaling
- Vol. 18 (2) , e12022
Adipocyte enhancer binding protein 1 knockdown alleviates osteoarthritis through inhibiting NF‐κB signaling pathway‐mediated inflammation and extracellular matrix degradation
Inflammation promotes the degradation of the extracellular matrix, which contributes to the development of osteoarthritis (OA). Adipocyte enhancer binding protein 1 (AEBP1) participates in multiple pathological processes related to inflammatory diseases. However, the role of AEBP1 in OA development is unknown. We found a higher AEBP1 expression in articular cartilage of OA patients (n = 20) compared to their normal controls (n = 10). Thus, we inferred that AEBP1 might affect OA progression. Then mice with destabilization of the medial meniscus (DMM) surgery and chondrocytes with IL‐1β treatment (10 ng/mL) were used to mimic OA. The increased AEBP1 expression was observed in models of OA. AEBP1 knockdown in chondrocytes reversed IL‐1β‐induced inflammation and extracellular matrix degradation, which was mediated by the inactivation of NF‐κB signaling pathway and the increased IκBα activity. Co‐immunoprecipitation assay indicated the interaction between AEBP1 and IκBα. Importantly, IκBα knockdown depleted the protective role of AEBP1 knockdown in OA. Moreover, AEBP1 knockdown in mice with OA showed similar results to those in chondrocytes. Collectively, our findings suggest that AEBP1 knockdown alleviates the development of OA, providing a novel strategy for OA treatment.
- 22 March 2024
- Published by Wiley in Journal of Cell Communication and Signaling
- Vol. 18 (2) , e12022
Open AccessAdipocyte enhancer binding protein 1 knockdown alleviates osteoarthritis through inhibiting NF‐κB signaling pathway‐mediated inflammation and extracellular matrix degradation
Inflammation promotes the degradation of the extracellular matrix, which contributes to the development of osteoarthritis (OA). Adipocyte enhancer binding protein 1 (AEBP1) participates in multiple pathological processes related to inflammatory diseases. However, the role of AEBP1 in OA development is unknown. We found a higher AEBP1 expression in articular cartilage of OA patients (n = 20) compared to their normal controls (n = 10). Thus, we inferred that AEBP1 might affect OA progression. Then mice with destabilization of the medial meniscus (DMM) surgery and chondrocytes with IL‐1β treatment (10 ng/mL) were used to mimic OA. The increased AEBP1 expression was observed in models of OA. AEBP1 knockdown in chondrocytes reversed IL‐1β‐induced inflammation and extracellular matrix degradation, which was mediated by the inactivation of NF‐κB signaling pathway and the increased IκBα activity. Co‐immunoprecipitation assay indicated the interaction between AEBP1 and IκBα. Importantly, IκBα knockdown depleted the protective role of AEBP1 knockdown in OA. Moreover, AEBP1 knockdown in mice with OA showed similar results to those in chondrocytes. Collectively, our findings suggest that AEBP1 knockdown alleviates the development of OA, providing a novel strategy for OA treatment.
- 20 September 2023
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 747, 109764
SNIP1 reduces extracellular matrix degradation and inflammation via inhibiting the NF-κB signaling pathway in osteoarthritis
- 20 September 2023
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 747, 109764
SNIP1 reduces extracellular matrix degradation and inflammation via inhibiting the NF-κB signaling pathway in osteoarthritis
- 18 May 2023
- Published by Elsevier in Experimental Cell Research
- Vol. 429 (1) , 113648
BASP1 knockdown suppresses chondrocyte apoptosis and extracellular matrix degradation in vivo and in vitro: A possible therapeutic approach for osteoarthritis
- 18 May 2023
- Published by Elsevier in Experimental Cell Research
- Vol. 429 (1) , 113648
BASP1 knockdown suppresses chondrocyte apoptosis and extracellular matrix degradation in vivo and in vitro: A possible therapeutic approach for osteoarthritis
- Open Access
- 1 February 2019
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 1225-1235
Knockdown of EIF3C promotes human U-2OS cells apoptosis through increased CAS P3/7 and Chk1/2 by upregulating SAPK/JNK
Background: As a component of the EIF3 complex, EIF3C is essential for several steps in protein synthesis initiation. Recently, it has been addressed that EIF3C is overexpressed in several human cancers and plays a pivotal role in cell proliferation and tumorigenesis. Materials and methods: Immunohistochemistry, quantitative real-time PCR (qPCR), and Western blotting assays were employed to determine the expression of EIF3C in osteosarcoma (OsC) tissues obtained from 60 patients. The levels of EIF3C mRNA and protein were assessed by qPCR and Western blotting, respectively. The effect of EIF3C knockdown on OsC cell proliferation was detected by MTT and colony formation assays, respectively. Cell apoptosis induced by EIF3C silencing was analyzed by flow cytometric analysis. PathScan stress and apoptosis signaling antibody array kit was used to analyze the potential effects of EIF3C knockdown on OsC cells. Results: The levels of EIF3C were high in OsC tissues and cell lines. In addition, EIF3C knockdown by lentivirus-mediated shRNA targeting EIF3C significantly suppressed cell proliferation and colony formation and induced apoptosis in U-2OS cells. Moreover, EIF3C knockdown led to the upregulated expression of CASP3/7, Chk1/2, and SAPK/JNK, indicating that the downregulated expression of EIF3C might be associated with pro-apoptosis of U-2OS cells. Conclusion: EIF3C may be a promising target for gene therapy of human OsC. However, the precise mechanisms behind the effect of EIF3C on OsC tumorigenesis require further analysis.
- 1 February 2019
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 1225-1235
Open AccessKnockdown of EIF3C promotes human U-2OS cells apoptosis through increased CAS P3/7 and Chk1/2 by upregulating SAPK/JNK
Background: As a component of the EIF3 complex, EIF3C is essential for several steps in protein synthesis initiation. Recently, it has been addressed that EIF3C is overexpressed in several human cancers and plays a pivotal role in cell proliferation and tumorigenesis. Materials and methods: Immunohistochemistry, quantitative real-time PCR (qPCR), and Western blotting assays were employed to determine the expression of EIF3C in osteosarcoma (OsC) tissues obtained from 60 patients. The levels of EIF3C mRNA and protein were assessed by qPCR and Western blotting, respectively. The effect of EIF3C knockdown on OsC cell proliferation was detected by MTT and colony formation assays, respectively. Cell apoptosis induced by EIF3C silencing was analyzed by flow cytometric analysis. PathScan stress and apoptosis signaling antibody array kit was used to analyze the potential effects of EIF3C knockdown on OsC cells. Results: The levels of EIF3C were high in OsC tissues and cell lines. In addition, EIF3C knockdown by lentivirus-mediated shRNA targeting EIF3C significantly suppressed cell proliferation and colony formation and induced apoptosis in U-2OS cells. Moreover, EIF3C knockdown led to the upregulated expression of CASP3/7, Chk1/2, and SAPK/JNK, indicating that the downregulated expression of EIF3C might be associated with pro-apoptosis of U-2OS cells. Conclusion: EIF3C may be a promising target for gene therapy of human OsC. However, the precise mechanisms behind the effect of EIF3C on OsC tumorigenesis require further analysis.
- 1 March 2014
- Published by Elsevier in Neuroscience Letters
- Vol. 562, 54-59
Epidermal growth factor increases the expression of Nestin in rat reactive astrocytes through the Ras–Raf–ERK pathway
- 1 March 2014
- Published by Elsevier in Neuroscience Letters
- Vol. 562, 54-59
Epidermal growth factor increases the expression of Nestin in rat reactive astrocytes through the Ras–Raf–ERK pathway
- Open Access
- 6 February 2013
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 7 (4) , 1143-1148
Chordin-like protein 1 promotes neuronal differentiation by inhibiting bone morphogenetic protein-4 in neural stem cells
In the present study, the effects of chordin‑like protein 1 (CHRDL1) overexpression, together with bone morphogenetic protein‑4 (BMP‑4) treatment, on the differentiation of rat spinal cord‑derived neural stem cells (NSCs) was investigated. Adult rat spinal cord‑derived NSCs were cultured in serum‑free medium. The recombined eukaryotic expression vector pSecTag2/Hygro B‑CHRDL1 was transfected into adult rat spinal cord‑derived NSCs using a lipid‑based transfection reagent and protein expression was assessed by western blot analysis. Differentiation of transfected NSCs following BMP‑4 treatment was determined by immunocytochemistry. The percentage of microtubule‑associated protein‑2 (MAP‑2)‑positive cells in the BMP‑4‑treated (B) group was found to be significantly lower compared with that in the non‑transfected control (N) group. The percentage of MAP‑2‑positive cells in the pSecTag2/Hygro B‑CHRDL1‑transfected, BMP‑4‑treated group was identified to be significantly higher compared with that in group B, however, no significant difference was observed between group N and the transfected, non‑BMP‑4‑treated control group. The current study indicates that CHRDL1 protein antagonizes BMP‑4 activity and induces spinal cord‑derived NSCs to differentiate into neurons.
- 6 February 2013
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 7 (4) , 1143-1148
Open AccessChordin-like protein 1 promotes neuronal differentiation by inhibiting bone morphogenetic protein-4 in neural stem cells
In the present study, the effects of chordin‑like protein 1 (CHRDL1) overexpression, together with bone morphogenetic protein‑4 (BMP‑4) treatment, on the differentiation of rat spinal cord‑derived neural stem cells (NSCs) was investigated. Adult rat spinal cord‑derived NSCs were cultured in serum‑free medium. The recombined eukaryotic expression vector pSecTag2/Hygro B‑CHRDL1 was transfected into adult rat spinal cord‑derived NSCs using a lipid‑based transfection reagent and protein expression was assessed by western blot analysis. Differentiation of transfected NSCs following BMP‑4 treatment was determined by immunocytochemistry. The percentage of microtubule‑associated protein‑2 (MAP‑2)‑positive cells in the BMP‑4‑treated (B) group was found to be significantly lower compared with that in the non‑transfected control (N) group. The percentage of MAP‑2‑positive cells in the pSecTag2/Hygro B‑CHRDL1‑transfected, BMP‑4‑treated group was identified to be significantly higher compared with that in group B, however, no significant difference was observed between group N and the transfected, non‑BMP‑4‑treated control group. The current study indicates that CHRDL1 protein antagonizes BMP‑4 activity and induces spinal cord‑derived NSCs to differentiate into neurons.